The exposition of monocytes to lipopolysaccharide (LPS) primarily causes a massive inflammatory response that is then followed by a hyporesponsive state of these cells. This latter state is called endotoxin tolerance and is characterized by (i) the attenuated production of proinflammatory mediators after repeated LPS treatment, and (ii) the diminished antigen presentation and T-cell stimulation capacity. The data presented here indicate that LPS priming causes a specific decrease in the expression of legumain (the asparaginyl endopeptidase responsible for the key step in antigen processing) in monocytes. In these cells, the fraction of major histocompatibility complex (MHC) class II loaded with CLIP was increased. In contrast to monocytes, LPS priming provoked an increase of legumain expression in B cells. Reduced monocytic expression of legumain was also found in critically ill patients supporting the suitability of endotoxin tolerance as an experimental model of clinical postinflammatory immunodeficiency.
The exposition of monocytic cells to even minor amounts of bacterial lipopolysaccharide (LPS or endotoxin) causes a massive inflammatory response in these cells. 1 They synthesize and secrete a multitude of cytokines (eg TNFa, IL-1b, IL-6, IL-12, G-CSF, GM-CSF, M-CSF), chemokines (eg IL-8, MCP-1), lipid-derived mediators (eg prostagladins), and other soluble agents (eg NO). Moreover, LPS treatment of these cells strengthens the expression of the major histocompatibility complex (MHC) class II and adhesion molecules. 2, 3 However, a few hours after the massive inflammatory response, these cells reach an entirely different functional state without any new treatment or change in the environment; they become hyporesponsive. 4 As monocytes in this state are only able to produce minor amounts of proinflammatory mediators upon repeated LPS stimulation, this state is known as endotoxin tolerance. 5, 6 Interestingly, monocytes in endotoxin tolerance also show reduced antigen presentation, which is associated with diminished stimulation capacity of CD4 þ T cells. 3, 7 There are numerous studies that have investigated the cause of attenuated production of proinflammatory mediators after repeated LPS treatment. [8] [9] [10] [11] [12] In contrast, there is hardly any research being focused on the mechanism of the reduced antigen presentation of LPSprimed monocytic cells. 13 Efficient antigen presentation requires two processes: the antigen processing and the expression of MHC class II.
14 Major antigen-presenting cells (APCs), such as monocytes, macrophages and dendritic cells, express a variety of pattern recognition receptors that recognize structures shared by many microbes. 15 Moreover, they express receptors for immunoglobulins as well as for the complement system components that enable them to take up opsonized antigens very efficiently. After phagocytosis, the antigens are contained within intracellular vesicles called phagosomes, which may fuse with lysosomes creating secondary lysosomes or endosomes. These acidic vesicles also contain proteolytic enzymes such as cathepsins and legumain. The enzymes that degrade the antigenic proteins for MHC class II pathway are not fully defined, and for many steps they may be redundant. 14, 16 However, legumain has been shown to be a key enzyme at least in the proteolytic degradation of tetanus toxin C fragment (TTCF). 17 It is responsible for the initial proteolytic step of TTCF. The elimination of legumainprocessing sites within this protein causes it to become highly resistant to proteolysis by other lysosomal enzymes and to not be presented to CD4 þ cells. 17, 18 Legumain is a cysteine endopeptidase with strict specificity for protein cleavage on the C-terminal side of asparagines. 19, 20 The activation of legumain is triggered by acidic pH and is autocatalytic.
For the expression of MHC class II, various accessory molecules are necessary in addition to the synthesis of MHC class II itself. 14, 22 The nonpolymorphic invariant chain CD74 associates with the freshly synthesized MHC class II molecules in the endoplasmic reticulum (ER), stabilizes their spatial structure and prevents premature peptide loading. With the help of two sorting signals, CD74 also leads the MHC class II to endosome compartments where antigens are proteolytically degraded. Cleavage of CD74 has been shown to take place in a stepwise manner by endopeptidases that remove the N-terminal endosome retention signal and leave MHC class II groove-binding parts referred to as CLIP. Cleavage of a 10 kDa CD74 fragment, p10, is performed in most APCs preferentially by the cysteine endopeptidase cathepsin S and seems to be the most critical step in the final generation of CLIP. 23, 24 Loading of the MHC class II with 10-30 amino-acid long antigenic peptides is known to take place in the so-called MHC class II loading compartment with the help of other accessory molecules such as the human leukocyte antigen DM (HLA-DM). 14, 22 The final step in the expression of MHC class II is its transport to the cell surface. The required stabilization of MHC class II by bound peptides ensures that only MHC class II complexes loaded with highaffinity peptides will survive long enough to reach and reside on the outer cell membrane. Recently, we found that the dramatic downregulation of MHC class II surface expression in endotoxin-tolerant monocytes was associated with the alteration of all of these steps required for efficient expression of MHC class II in these cells. 3, 13 In fact, LPS priming provoked (i) a decrease of monocyte intracellular MHC class II levels, (ii) a reduced synthesis of CD74, cathepsin S and HLA-DM, and (iii) a diminished export of mature MHC class II to the cell surface. 13 In the current study, we investigated whether LPS priming also has an impact on the expression of the key endopeptidase in antigen processing, legumain.
As hardly any data were available regarding the expression of legumain and its regulation in immune cells, we first studied the expression of legumain in comparison to other lysosomal enzymes in freshly isolated primary human monocytes. As deduced from real-time PCR on reverse transcribed mRNA (RT-PCR), monocytes clearly expressed legumain, although this expression was much lower than that of the other tested proteases that play a role in antigen processing, cathepsin B, cathepsin H, cathepsin L, cathepsin F and cathepsin S (Figure 1a ). This low expression and the fact that legumain activates lysosomal cathepsins and unlocks the antigens for splitting 18, 25 suggests that the level and activity of legumain regulates the antigen cleavage. Figure 1 The expression of legumain is reduced in endotoxintolerant monocytes. PBMCs were separated from the blood of healthy donors by Ficoll Paquet density-gradient centrifugation (Pharmacia, Freiburg, Germany). Monocytes (a-c) and B cells (d) were isolated from the PBMCs by the MACSt system (Miltenyi Biotec, Bergisch-Gladbach, Germany) directly after isolation (a) or after culture under conditions described previously 3, 13 in the presence (LPS primed) or absence (control) of 2 ng/ml Escherichia coli 0127 B8 LPS (Sigma-Aldrich, Deisenhofen, Germany) for 24 h, washing and reculture for a further 6 h (c) or for up to a further 48 h (b and d). mRNA expression was analyzed by real-time RT-PCR using the TaqMant system (Applied Biosystems, Weiterstadt, Germany) as described previously. 13, 34, 35 (a) mRNA expression of legumain, cathepsin B, cathepsin H, cathepsin L, cathepsin F and cathepsin S was analyzed in freshly isolated monocytes. Individual data obtained from six donors are indicated. (b) Monocytes were isolated from PBMCs before (0 h), during (12 h) and after (24, 48 ,and 72 h) priming period. Monocyte legumain expressions are given from duplicate measurements from one experiment (mean7range). (c) Monocytes were isolated from PBMCs 6 h after priming period. Monocyte expression of legumain, cathepsin B and cathepsin H are given from five experiments as the percentage of control (mean7s.e.). Significance of the difference between LPS-primed and control group was tested by Wilcoxon's matched-pairs signedrank test (*Po0.05). (d) B cells were isolated from PBMCs before (0 h), during (12 h) and after (24, 48 and 72 h) priming period. B-cell legumain expressions are given from duplicate measurements from one experiment (mean7range). We then investigated whether endotoxin tolerance would alter the monocyte expression of legumain. In a kinetic study, peripheral blood mononuclear cells (PBMCs) were primed or not (controls) for 24 h with LPS, and recultured for up to 72 h. Monocyte legumain mRNA expression was analyzed by real-time RT-PCR during and after LPS priming and compared to the untreated controls. After a transient upregulation at 12 h, legumain expression was downregulated at the end of the LPS priming period (at 24 h), then decreased further reaching minimal expression 24 h after LPS priming (at 48 h) and recovered at 72 h (Figure 1b) . As shown in Figure 1c , LPS-induced downregulation of monocyte legumain expression was significant at 30 h.
We have previously shown that cathepsin S expression is also downregulated in LPS-primed monocytes. 13 To investigate whether downregulation of lysosomal enzymes is a general feature of endotoxin tolerance, we additionally determined cathepsin B and H mRNA expression in LPS-primed monocytes. As shown in Figure 1c , LPS priming slightly upregulated these expressions.
We then asked whether downregulation of legumain would also occur in other abundant APCs of the peripheral blood such as B cells. Again, PBMCs were primed for 24 h with LPS, and recultured for up to 72 h. The analysis of B-cell legumain expression was performed before, during and after LPS priming by realtime RT-PCR. In contrast to monocytes, B cells showed upregulated legumain expression after the LPS priming period that recovered at 72 h (Figure 1d) .
We speculated that decreased legumain expression in LPS-primed monocytes would be associated with a decreased amount of available peptides for the MHC class II loading, and thus the amount of MHC class II bound to CLIP would correspondingly increase. We therefore measured the expression of MHC class II and CLIP at the cell surface at 24 h after LPS priming by flow cytometry and then calculated the proportion of CLIPloaded MHC class II. As shown in Figure 2a , CLIP presentation was very low in both monocytes and B cells. LPS priming in monocytes, in contrast to B cells, effectively led to a slight although significant increase in the amount of CLIP-loaded MHC class II. Since the CLIP-loaded MHC class II complexes are unstable, it is probable that the reduced legumain expression also contributes to the reduction of MHC class II expression observed in endotoxin-tolerant monocytes. This might be also supported by the clear positive correlation between the level of legumain expression and the HLA-DR expression of these cells (Spearman's correlation coefficient ¼ 0.732, Po0.05).
As demonstrated in earlier studies, experimental endotoxin tolerance shows some features of clinical postinflammatory immunodeficiency. 3, 26, 27 In patients after major surgery, polytrauma or burns, the so-called systemic inflammatory response syndrome (SIRS) is frequently followed by a temporary immunodeficiency. [28] [29] [30] [31] [32] This life-threatening state is identifiable solely by immunological laboratory parameters. As observed in the experimental system, blood monocytes from these patients show strongly reduced antigen presentation and produce only minor amounts of proinflammatory cytokines in response to LPS. We therefore asked whether legumain expression would also be modified in critically ill patients from intensive care unit (ICU) with pathological immunocompetence determined by the reduced monocyte MHC class II expression. As demonstrated in Figure 2b , monocyte mRNA expression of legumain in these patients was slightly but significantly decreased compared to that of healthy participants. Moreover, this expression positively correlated with the expression of HLA-DR on these cells (Spearman's correlation coefficient ¼ 0.783, Po0.01).
In summary, we have found that LPS priming leads to reduced expression of legumain, the lysosomal asparaginyl endopeptidase responsible for the key step in antigen processing, specifically in monocytes. 17, 18 This decreased expression apparently leads to a decrease in the splitting of antigens and a dearth of available peptides for the MHC class II loading in endotoxintolerant monocytes. This dearth of available peptides, together with the decreased HLA-DM expression, 13 was reflected by increased amounts of CLIP-loaded MHC class II on the monocytic cell surface. The increase Monocytes and B cells were analyzed by flow cytometry as described previously. 3, 13 Individual data from five donors analyzed in independent experiments are given as the ratio of CLIP and HLA-DR/DP/DQ expression multiplied by 100 (mean7s.e.). Significance of the difference between LPS-primed and control groups was tested by Wilcoxon's matched-pairs signedrank test (*Po0.05). (b) Monocytes from the blood of immunodeficient patients from surgical ICU suffering from abdominal diseases (eg colitis ulcerosa, peritonitis), and from healthy control donors were isolated from PBMCs, obtained by Ficoll Paquet densitygradient centrifugation (Pharmacia, Freiburg, Germany), using MACSt system (Miltenyi Biotec, Bergisch-Gladbach, Germany). Immunodeficiency of patients was determined by pathological monocyte HLA-DR expressions (less than 10 000 molecules/cell, measured by the Quantibritet systems, and the FACS Caliburt with associated Cellquestt and Quanticalct software; BD Bioscience, Heidelberg, Germany). Legumain mRNA expression was analyzed by real-time RT-PCR using the TaqMant system (Applied Biosystems, Weiterstadt, Germany) as described previously. 13, 34, 35 Data from six participants per group are given as mean7s.e. Significance of the difference between LPS-primed and control groups was tested by Mann-Whitney U-test (*Po0.05).
of rather unstable CLIP-loaded MHC class II may also enhance the reduction of the MHC class II expression on these cells. Therefore, the reduced legumain expression might contribute indirectly (via the reduced MHC class II expression) and directly to the diminished T-cell stimulation capacity of endotoxintolerant monocytes.
The finding of reduced legumain expression in endotoxin-tolerant monocytes complements our understanding of the mechanisms of diminished antigenic T-cell stimulation capacity of these cells. The endotoxin-tolerant monocytes show (i) a reduced cell surface expression of mature MHC class II due to the reduced synthesis of MHC class II itself and accessory molecules responsible for MHC class II protein structure, transport and peptide loading, as well as to the reduced export of MHC class II complexes to the cell surface, 13 (ii) a reduced availability of antigenic peptides due to altered antigen processing in these cells, (iii) a diminished costimulatory activity due to downregulated expression of cell-standing and soluble molecules such as CD86, CD58, IL-12 and IL-1b (manuscript in preparation and Wolk et al 3 and Karp et al 6 ). Interestingly, for many of these changes, we could demonstrate that they are specific for monocytic cells and are not observed in B cells. It should be noted that the contribution of each individual mechanism to the reduced T-cell stimulation in endotoxin tolerance is currently not known.
We also found that legumain expression was reduced in monocytes of patients with postinflammatory immunodeficiency. As immunodeficiency is a life-threatening state, there is a tremendous need to research and understand the molecular mechanisms of this state. These patients are predisposed to contract nosocomial infections that are, however, difficult to identify since they are scarcely associated with any clinical symptoms. Moreover, these infections cannot be fought by the enfeebled immune system of such patients, and even with antibiotic treatment, these infections may evolve into sepsis. It is therefore not surprising that sepsis and resultant multiple organ failure are the most common causes of death in ICUs. 33 Our finding appears to be important for two reasons. First of all, it supports the acceptance of endotoxin tolerance as an experimental model for postinflammatory immunodeficiency. Secondly, the reduced legumain expression may be partially responsible for the refractory functional state of the monocytes in these patients and may therefore contribute to their immunodeficiency. New therapeutic approaches to strengthen the immune defense in these patients should therefore consider both the reduced expression of MHC class II and the reduced supply of and loading with antigenic peptides.
